[Form 4] Fabrinet Insider Trading Activity

Rhea-AI Filing Summary

Fabrinet (FN) reporting person Edward T. Archer, EVP Sales & Marketing, disclosed insider sales on 09/04/2025. The Form 4 shows three separate dispositions of ordinary shares: 1,300 shares sold at a weighted average price of $353.676, 1,533 shares sold at a weighted average price of $354.88, and 500 shares sold at a weighted average price of $355.327. The report lists sequential beneficial ownership after each sale of 8,677 shares, 7,144 shares, and 6,644 shares respectively, indicating a total of 3,333 shares disposed on that date. The filing includes explanatory notes that the reported prices are weighted averages over small price ranges and states that full per-price details will be provided upon request.

Positive

• None.

Negative

• Insider selling: Edward T. Archer disposed of a total of 3,333 FN ordinary shares on 09/04/2025, reducing his beneficial ownership to 6,644 shares.
• No 10b5-1 disclosure: The form does not indicate the sales were made pursuant to a Rule 10b5-1 trading plan or other pre-arranged program.

Insights

Securities Analyst

TL;DR: Company insider sold 3,333 FN shares on 09/04/2025 at weighted averages near $354, reducing reported beneficial holdings to 6,644 shares.

The transactions are disclosed as routine dispositions by Edward T. Archer, EVP Sales & Marketing, and are recorded as direct holdings reductions in a single-day cluster of three sales. The filing provides weighted average sale prices and the progressive post-transaction share counts, enabling precise tracking of the insider's holding change. No derivative transactions or 10b5-1 plan flag is indicated on the face of the form. From a market perspective, these are material for transparency around insider activity but the filing does not include any explanatory motive or link to corporate events.

Corporate Governance Expert

TL;DR: Insider disposal documented clearly; disclosure meets Form 4 presentation standards but contains no stated plan or rationale.

The Form 4 is properly executed and signed by an attorney-in-fact, includes explanatory price-range notes, and reports direct ownership changes. It does not indicate that the sales were made pursuant to a Rule 10b5-1 trading plan or other pre-arranged program. For governance review, the factual record is complete for the reported transactions but lacks context about whether sales were routine diversification or for other reasons; the filing limits itself to transaction mechanics and post-sale holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Archer Edward T.

(Last) (First) (Middle)

C/O FABRINET USA, INC.

3736 FALLON ROAD #428

(Street)

DUBLIN CA 94568

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fabrinet [ FN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Sales & Marketing

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/04/2025		S		1,300	D	$353.676(1)	8,677	D
Ordinary Shares	09/04/2025		S		1,533	D	$354.88(2)	7,144	D
Ordinary Shares	09/04/2025		S		500	D	$355.327(3)	6,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale price represents the weighted average sale price of the shares sold ranging from $353.18 to $354.155 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

2. This sale price represents the weighted average sale price of the shares sold ranging from $354.18 to $355.178 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

3. This sale price represents the weighted average sale price of the shares sold ranging from $355.20 to $355.625 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	Andrew Chew, Attorney-in-fact for Edward T. Archer	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Edward T. Archer report on the Form 4 for Fabrinet (FN)?

He reported three sales on 09/04/2025 totaling 3,333 shares with weighted average prices of $353.676, $354.88, and $355.327 and ending beneficial ownership of 6,644 shares.

When were the FN share transactions executed?

All three reported dispositions were executed on 09/04/2025.

How many shares did Archer hold after the reported sales?

The Form 4 shows progressive post-sale beneficial ownership counts of 8,677, 7,144, and finally 6,644 shares.

Are the reported sale prices exact?

The filing states each reported price is a weighted average over a specified per-share price range and that full per-price details will be provided upon request.

Was the sale made under a 10b5-1 plan according to the filing?

The Form 4 does not indicate the transactions were made pursuant to a 10b5-1 trading plan.